Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2285829 | 1.00 | SOAT1 (0.41) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2280747 | 1.00 | SOAT1 (0.41) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2289871 | 1.00 | SOAT1 (0.41) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2286412 | 1.00 | SOAT1 (0.41) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2278419 | 1.00 | SOAT1 (0.41) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2285813 | 0.98 | SOAT1 (0.38) | SOAT1CYP3A4MEN1KMT2AFAAH | |
| SCHEMBL2288400 | 0.91 | — | — | |
| SCHEMBL15149578 | 0.84 | ALDH1A1 (0.37) | CYP3A4KMT2AFAAHALDH1A1GAA | |
| SCHEMBL2282542 | 0.83 | — | — | |
| SCHEMBL2282017 | 0.82 | ALDH1A1 (0.56) | MEN1KMT2AALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115485279-A | Antibacterial 8-phenylamino-3- (pyrazol-4-yl) imidazo [1,2-a ] pyrazine derivatives | 豪夫迈·罗氏有限公司 | 2022-12-16 | — | — | CN | claimed |
| US-7994273-B2 | Photoactive materials | ROLIC AG (CH) | 2011-08-09 | — | — | US | claimed |
| US-7750185-B2 | Photoactive materials | ROLIC AG (CH) | 2010-07-06 | — | — | US | claimed |
| CN-100551902-C | light active material | ROLIC AG (CH) | 2009-10-21 | — | — | CN | claimed |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | ROLIC AG (CH) | 2005-12-29 | — | — | US | claimed |
| CN-1671648-A | photoactive material | ROLIC AG (CH) | 2005-09-21 | — | — | CN | claimed |
| EP-1386910-A1 | Photoactive materials | Rolic AG (CH) | 2004-02-04 | — | — | EP | claimed |
| CN-113717161-B | Nitrogen-containing saturated heterocyclic compound, preparation method thereof, pharmaceutical composition and application | 广州费米子科技有限责任公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-115991703-A | Ring-fused compound, preparation method thereof, pharmaceutical composition and application | 广州费米子科技有限责任公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-115485279-A | Antibacterial 8-phenylamino-3- (pyrazol-4-yl) imidazo [1,2-a ] pyrazine derivatives | 豪夫迈·罗氏有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-113717167-B | Fused ring compound, preparation method thereof, pharmaceutical composition and application | 广州费米子科技有限责任公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-113717161-A | Nitrogen-containing saturated heterocyclic compound and preparation method, pharmaceutical composition and application thereof | 广州费米子科技有限责任公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-113717167-A | Fused ring compound, preparation method thereof, pharmaceutical composition and application | 广州费米子科技有限责任公司 | 2021-11-30 | — | — | CN | disclosed |
| US-8436132-B2 | Photoactive materials | ROLIC AG (CH) | 2013-05-07 | — | — | US | disclosed |
| US-20110236602-A1 | PHOTOACTIVE MATERIALS | ROLIC AG (CH) | 2011-09-29 | — | — | US | disclosed |
| US-7994273-B2 | Photoactive materials | ROLIC AG (CH) | 2011-08-09 | — | — | US | disclosed |
| US-20100272979-A1 | PHOTOACTIVE MATERIALS | ROLIC AG (CH) | 2010-10-28 | — | — | US | disclosed |
| US-7750185-B2 | Photoactive materials | ROLIC AG (CH) | 2010-07-06 | — | — | US | disclosed |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | ROLIC AG (CH) | 2005-12-29 | — | — | US | disclosed |
| EP-1386910-A1 | Photoactive materials | Rolic AG (CH) | 2004-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110236602-A1 | PHOTOACTIVE MATERIALS | AOC1, CRY1, CCNA1 | SOAT1 4026/4885CYP3A4 3690/4885MEN1 878/4885 |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | C9, F12, DAO | SOAT1 3724/4885CYP3A4 4704/4885MEN1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.